Home
RVTY
RVTY News

Latest Revvity Inc. (RVTY) News on February 23, 2025

MT Newswires

2 days ago

Revvity Wins Permanent Injunction Against Cloud Software Group

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Business Wire

2 days ago

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Revvity to Present at Upcoming Investor Conferences

Business Wire

3 days ago

Revvity to Present at Upcoming Investor Conferences

Argus Research

4 days ago

RVTY: Rating decreased to a SELL

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years”

Insider Monkey

4 days ago

Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years”

Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Simply Wall St.

15 days ago

Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Argus Research

18 days ago

RVTY: Lowering target price to $129.00

MT Newswires

19 days ago

Raymond James Adjusts Price Target on Revvity to $145 From $140

MT Newswires

19 days ago

KeyBanc Adjusts Revvity Price Target to $145 From $132

MT Newswires

20 days ago

Bernstein Adjusts Revvity Price Target to $140 From $130, Maintains Market Perform Rating

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

GuruFocus.com

22 days ago

Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

Thomson Reuters StreetEvents

22 days ago

Q4 2024 Revvity Inc Earnings Call

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

StockStory

22 days ago

Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations

Morningstar Research

22 days ago

Analyst Report: Revvity, Inc.

MT Newswires

22 days ago

Citigroup Raises Price Target on Revvity to $155 From $145

RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust

Zacks

22 days ago

RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust

MT Newswires

22 days ago

Evercore ISI Adjusts Price Target on Revvity to $138 From $125

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

23 days ago

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say

Revvity (RVTY) Surpasses Q4 Earnings Estimates

Zacks

23 days ago

Revvity (RVTY) Surpasses Q4 Earnings Estimates

MT Newswires

23 days ago

Revvity Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Up Pre-Bell

Associated Press Finance

23 days ago

Revvity: Q4 Earnings Snapshot

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Business Wire

23 days ago

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

24 days ago

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Revvity Gears Up for Q4 Earnings: What's in the Offing?

Zacks

25 days ago

Revvity Gears Up for Q4 Earnings: What's in the Offing?

Argus Research

25 days ago

RVTY: Raising target price to $132.00

MT Newswires

a month ago

Baird Adjusts Revvity Price Target to $137 From $138, Maintains Outperform Rating

Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barron’s Roundtable

Barrons.com

a month ago

Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barron’s Roundtable

Revvity (RVTY) Earnings Expected to Grow: Should You Buy?

Zacks

a month ago

Revvity (RVTY) Earnings Expected to Grow: Should You Buy?

Revvity Board Declares Quarterly Dividend

Business Wire

a month ago

Revvity Board Declares Quarterly Dividend

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Zacks

a month ago

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Argus Research

a month ago

RVTY: Raising target price to $130.00

MT Newswires

a month ago

Raymond James Adjusts Revvity Price Target to $140 From $146

Argus Research

a month ago

RVTY: Raising target price to $127.00

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Zacks

a month ago

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Business Wire

a month ago

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Business Wire

a month ago

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Revvity wins FDA clearance for ChLIA assay in free testosterone measurement

Medical Device Network

a month ago

Revvity wins FDA clearance for ChLIA assay in free testosterone measurement

MT Newswires

a month ago

Revvity Secures FDA Clearance for Automated Free Testosterone Test

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

Business Wire

a month ago

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

MT Newswires

a month ago

Bernstein Downgrades Revvity to Market Perform From Outperform, Adjusts Price Target to $130 From $145

No time to waste: Revvity CFO Max Krakowiak

CFO.com

a month ago

No time to waste: Revvity CFO Max Krakowiak

MT Newswires

2 months ago

Evercore ISI Adjusts Price Target on Revvity to $125 From $134

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks

2 months ago

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Argus Research

2 months ago

RVTY: Lowering target price to $118.00

Argus Research

2 months ago

RVTY: Lowering target price to $120.00

Revvity to Present at J.P. Morgan Healthcare Conference

Business Wire

2 months ago

Revvity to Present at J.P. Morgan Healthcare Conference

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst

Benzinga

2 months ago

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst

MT Newswires

2 months ago

BofA Securities Upgrades Revvity to Buy From Neutral

Argus Research

2 months ago

RVTY: Raising target price to $124.00

Can Revvity, Inc. (NYSE:RVTY) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Simply Wall St.

2 months ago

Can Revvity, Inc. (NYSE:RVTY) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report?

Zacks

3 months ago

Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report?

Argus Research

3 months ago

RVTY: What does Argus have to say about RVTY?

Argus Research

3 months ago

RVTY: Raising target price to $121.00

Revvity price target lowered to $135 from $140 at Barclays

TipRanks

3 months ago

Revvity price target lowered to $135 from $140 at Barclays

MT Newswires

3 months ago

Barclays Adjusts Price Target on Revvity to $135 From $140, Keeps Overweight Rating

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Business Wire

3 months ago

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Business Wire

3 months ago

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Business Wire

3 months ago

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

Business Wire

3 months ago

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative

Simply Wall St.

3 months ago

We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative

Argus Research

3 months ago

RVTY: Lowering target price to $126.00

Argus Research

4 months ago

RVTY: Raising target price to $132.00

MT Newswires

4 months ago

UBS Raises Revvity Price Target to $145 From $140, Maintains Neutral Rating

MT Newswires

4 months ago

Baird Adjusts Price Target on Revvity to $138 From $136, Maintains Outperform Rating

MT Newswires

4 months ago

TD Cowen Adjusts Price Target on Revvity to $144 From $141, Maintains Buy Rating

MT Newswires

4 months ago

Bernstein Adjusts Price Target on Revvity to $145 From $150, Maintains Outperform Rating

MT Newswires

4 months ago

Raymond James Adjusts Price Target on Revvity to $146 From $144, Maintains Outperform Rating

Revvity Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

4 months ago

Revvity Third Quarter 2024 Earnings: EPS Beats Expectations

Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges

GuruFocus.com

4 months ago

Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges

Thomson Reuters StreetEvents

4 months ago

Q3 2024 Revvity Inc Earnings Call

MT Newswires

4 months ago

Goldman Sachs Raises Price Target on Revvity to $140 From $130

RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised

Zacks

4 months ago

RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised

Morningstar Research

4 months ago

Analyst Report: Revvity, Inc.

MT Newswires

4 months ago

Evercore ISI Adjusts Price Target on Revvity to $134 From $132

MT Newswires

4 months ago

Update: Revvity Shares Rise After Higher Q3 Results; 2024 Adjusted Earnings Guidance Lifted

Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings

Zacks

4 months ago

Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings

Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates

Zacks

4 months ago

Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates

MT Newswires

4 months ago

Revvity's Q3 Adjusted Earnings, Revenue Rise; Updates 2024 Outlook

Associated Press Finance

4 months ago

Revvity: Q3 Earnings Snapshot

Revvity Announces Financial Results for the Third Quarter of 2024

Business Wire

4 months ago

Revvity Announces Financial Results for the Third Quarter of 2024

Revvity to Report Q3 Earnings: What's in Store for the Stock?

Zacks

4 months ago

Revvity to Report Q3 Earnings: What's in Store for the Stock?

MultiPlan Corporation (MPLN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

4 months ago

MultiPlan Corporation (MPLN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Earnings Preview: Revvity (RVTY) Q3 Earnings Expected to Decline

Zacks

4 months ago

Earnings Preview: Revvity (RVTY) Q3 Earnings Expected to Decline

Calculating The Fair Value Of Revvity, Inc. (NYSE:RVTY)

Simply Wall St.

4 months ago

Calculating The Fair Value Of Revvity, Inc. (NYSE:RVTY)

Revvity Board Declares Quarterly Dividend

Business Wire

4 months ago

Revvity Board Declares Quarterly Dividend

Revvity Shares Decline Despite Launch of Transcribe AI Solution

Zacks

4 months ago

Revvity Shares Decline Despite Launch of Transcribe AI Solution

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories

Business Wire

4 months ago

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report

Business Wire

4 months ago

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report

MT Newswires

4 months ago

Leerink Adjusts Price Target on Revvity to $135 From $130

MT Newswires

4 months ago

Bernstein Adjusts Revvity Price Target to $150 From $145, Maintains Outperform Rating

MT Newswires

4 months ago

Barclays Upgrades Revvity to Overweight, Price Target is $140

Revvity Ramps Up R&D Spending Since PerkinElmer Split

The Wall Street Journal

4 months ago

Revvity Ramps Up R&D Spending Since PerkinElmer Split

QIAGEN's TB Testing Business Gets New Exposure at Global Summit

Zacks

4 months ago

QIAGEN's TB Testing Business Gets New Exposure at Global Summit

RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's Disease

Zacks

4 months ago

RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's Disease

Bionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

GuruFocus.com

4 months ago

Bionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

Argus Research

4 months ago

RVTY: Lowering target price to $128.00

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks

5 months ago

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Investing in Revvity (NYSE:RVTY) five years ago would have delivered you a 53% gain

Simply Wall St.

5 months ago

Investing in Revvity (NYSE:RVTY) five years ago would have delivered you a 53% gain

Revvity To Hold Earnings Call on Monday, November 4, 2024

Business Wire

5 months ago

Revvity To Hold Earnings Call on Monday, November 4, 2024

MT Newswires

5 months ago

Revvity Launches APOE Genotyping Test in Europe

Share on Social Networks: